Alterations in the ribosomal machinery in cancer and hematologic disorders.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3438023)

Published in J Hematol Oncol on June 18, 2012

Authors

Niraj Shenoy1, Rachel Kessel, Tushar D Bhagat, Sanchari Bhattacharyya, Yiting Yu, Christine McMahon, Amit Verma

Author Affiliations

1: Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10467, USA.

Articles citing this

Dysregulation of RNA polymerase I transcription during disease. Biochim Biophys Acta (2012) 1.16

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med Res Rev (2014) 0.98

Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress. Nucleic Acids Res (2013) 0.85

Photoaffinity labeling in target- and binding-site identification. Future Med Chem (2015) 0.84

Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9. J Virol (2012) 0.84

RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors. RNA Biol (2013) 0.82

RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes. Mol Cancer (2014) 0.80

Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate. Cancer Cell Int (2014) 0.79

Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer. Cancer Res (2014) 0.77

LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method. Sci Rep (2017) 0.75

The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells. Oncotarget (2017) 0.75

Occurrence of colon tumors in a 16-year-old Japanese boy after hematopoietic stem cell transplantation for Diamond Blackfan anemia at age of 4: a case report. Int J Clin Exp Pathol (2015) 0.75

Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome. PLoS One (2013) 0.75

[Myelodysplastic syndromes. Epidemiology, molecular and morphological characteristics and risk stratification]. Pathologe (2013) 0.75

A Functional Role for the Monomethylated Gln-51 and Lys-53 Residues of the 49GGQTK53 Motif of eL42 from Human 80S Ribosomes. Open Biochem J (2017) 0.75

Ribosomopathy-like properties of murine and human cancers. PLoS One (2017) 0.75

Articles cited by this

The World Health Organization (WHO) classification of the myeloid neoplasms. Blood (2002) 10.87

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature (2008) 8.38

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med (2006) 8.16

Does the ribosome translate cancer? Nat Rev Cancer (2003) 6.89

X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82

The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet (1999) 6.23

N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J (2001) 4.85

Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet (2002) 4.62

Extraribosomal functions of ribosomal proteins. Trends Biochem Sci (1996) 4.25

DWARFISM IN THE AMISH. II. CARTILAGE-HAIR HYPOPLASIA. Bull Johns Hopkins Hosp (1965) 4.23

Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell (2005) 4.16

THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr (1964) 4.12

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med (2009) 4.03

Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet (2008) 4.02

MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer (2010) 3.64

Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med (2008) 3.53

How common are extraribosomal functions of ribosomal proteins? Mol Cell (2009) 3.51

Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol (1991) 3.45

Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet (2008) 3.29

Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science (2003) 3.18

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood (2008) 3.05

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med (2009) 2.89

Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell (2001) 2.86

Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum Mutat (2007) 2.73

Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell (1990) 2.70

Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group. Nat Genet (1996) 2.40

Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci U S A (2006) 2.39

The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A (2004) 2.27

Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene (2010) 2.25

Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet (2007) 2.23

Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood (2006) 2.22

Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood (2006) 2.16

Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood (2007) 1.93

Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev (2011) 1.89

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol (2008) 1.83

Phospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy. Mod Pathol (2007) 1.73

The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood (2007) 1.69

Functional equivalence of human X- and Y-encoded isoforms of ribosomal protein S4 consistent with a role in Turner syndrome. Nat Genet (1993) 1.63

Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A (2008) 1.63

Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis. J Cell Biol (1998) 1.57

Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a. EMBO J (1990) 1.54

Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Hum Mol Genet (2008) 1.52

Mandibulo-facial dysostosis. (Treacher-Collins syndrome). Am J Dis Child (1967) 1.49

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer. Leukemia (2009) 1.47

Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex. Nucleic Acids Res (2004) 1.45

Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet (2005) 1.40

Differential expression of ribosomal proteins in human normal and neoplastic colorectum. J Histochem Cytochem (2003) 1.36

Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest (2008) 1.29

Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience. Pediatr Allergy Immunol (2011) 1.23

Ribosomal proteins and colorectal cancer. Curr Genomics (2007) 1.23

Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLoS One (2010) 1.16

Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Bone Marrow Transplant (2001) 1.13

Overexpression of B-type cyclins alters chromosomal segregation. Oncogene (2002) 1.11

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. Blood (2011) 1.08

Ribosomal protein l19 is a prognostic marker for human prostate cancer. Clin Cancer Res (2006) 1.08

Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Res (2001) 1.07

Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29. Biochem Biophys Res Commun (2000) 1.05

Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol (2009) 0.96

Do ribosomopathies explain some cases of common variable immunodeficiency? Clin Exp Immunol (2010) 0.95

RPS2: a novel therapeutic target in prostate cancer. J Exp Clin Cancer Res (2009) 0.94

Ribosomal protein S6 is highly expressed in non-Hodgkin lymphoma and associates with mRNA containing a 5' terminal oligopyrimidine tract. Oncogene (2010) 0.91

Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. J Hematol Oncol (2012) 0.89

siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer. PLoS One (2011) 0.89

Increased expression of ribosomal protein S2 in liver tumors, posthepactomized livers, and proliferating hepatocytes in vitro. Acta Biochim Pol (2002) 0.86

The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes. Curr Opin Hematol (2007) 0.86

Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia. Eur J Pediatr (1996) 0.83

A genetic screen for dominant modifiers of a small-wing phenotype in Drosophila melanogaster identifies proteins involved in splicing and translation. Genetics (2005) 0.82

An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo. Mol Cancer (2010) 0.80

RPL36 as a prognostic marker in hepatocellular carcinoma. Pathol Int (2011) 0.79

Articles by these authors

(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science (2013) 4.88

Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol (2009) 2.48

Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One (2010) 2.10

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood (2012) 1.98

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. Blood (2008) 1.95

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res (2006) 1.82

The airborne metagenome in an indoor urban environment. PLoS One (2008) 1.81

High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res (2009) 1.80

Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem (2002) 1.72

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood (2010) 1.53

Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol (2013) 1.52

Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (2013) 1.49

Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut (2013) 1.48

Outcome from therapeutic hypothermia and EEG. J Clin Neurophysiol (2011) 1.48

Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood (2006) 1.48

Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet (2011) 1.47

Cancer biomarkers - current perspectives. Indian J Med Res (2010) 1.44

The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis. PLoS Pathog (2008) 1.43

Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. J Genet Couns (2011) 1.42

Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. Blood (2009) 1.37

Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood (2012) 1.36

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood (2012) 1.33

Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. Cancer Res (2006) 1.31

Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nat Immunol (2013) 1.28

Activation of protein kinase C delta by IFN-gamma. J Immunol (2003) 1.25

Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. J Immunol (2008) 1.22

Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J Biol Chem (2008) 1.16

Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest (2010) 1.16

Critical roles for IFN-beta in lymphoid development, myelopoiesis, and tumor development: links to tumor necrosis factor alpha. Proc Natl Acad Sci U S A (2003) 1.14

The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med (2012) 1.13

Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. Cancer Res (2005) 1.13

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer (2010) 1.12

Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment. Leuk Lymphoma (2008) 1.11

Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase. Cancer Res (2010) 1.10

Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes. Haematologica (2011) 1.08

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling. Blood (2013) 1.08

Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis. J Immunol (2013) 1.07

Activation of protein kinase C delta by all-trans-retinoic acid. J Biol Chem (2003) 1.06

Transforming growth factor-beta signaling in normal and malignant hematopoiesis. J Interferon Cytokine Res (2007) 1.06

Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood (2002) 1.06

Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res (2009) 1.04

Aberrant DNA methylation in malignant melanoma. Melanoma Res (2010) 1.04

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia. Br J Haematol (2011) 1.03

High deferral rates and poorer treatment outcomes for HCV patients with psychiatric and substance use comorbidities. Dig Dis Sci (2007) 1.03

DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer. Wiley Interdiscip Rev Syst Biol Med (2010) 1.03

p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle (2007) 1.02

Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem (2004) 1.02

Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol (2009) 1.01

Educational needs of primary care physicians regarding direct-to-consumer genetic testing. J Genet Couns (2011) 1.00

Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. Nucleic Acids Res (2013) 1.00

Vision problems, eye care history, and ocular protection among migrant farmworkers. Arch Environ Occup Health (2008) 1.00

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood (2012) 0.99

Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q. J Biol Chem (2011) 0.97

Meta-analysis of microarray studies reveals a novel hematopoietic progenitor cell signature and demonstrates feasibility of inter-platform data integration. PLoS One (2008) 0.96

Low-dose radiation therapy of cancer: role of immune enhancement. Expert Rev Anticancer Ther (2011) 0.96

Signal transduction inhibitors in treatment of myelodysplastic syndromes. J Hematol Oncol (2013) 0.95

Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y) (2013) 0.94

Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol (2012) 0.92

Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. Cancer Res (2012) 0.92

Green tobacco sickness and skin integrity among migrant Latino farmworkers. Am J Ind Med (2008) 0.91

High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. J Biol Chem (2013) 0.91

Abnormal platelet count is an independent predictor of mortality in the elderly and is influenced by ethnicity. Haematologica (2014) 0.89

Self report of skin problems among farmworkers in North Carolina. Am J Ind Med (2008) 0.89

Complex limbal choristoma in nevus sebaceous syndrome. Pediatr Dermatol (2012) 0.89

HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia. J Clin Invest (2014) 0.88

Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature. Am J Dermatopathol (2008) 0.88

Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma. Ann N Y Acad Sci (2013) 0.88

The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol (2009) 0.88

Kinase inhibitors translate lab discoveries into exciting new cures for cancers. Indian J Pediatr (2004) 0.87